Research news

liu labNon-toxic underwater adhesive could bring new surgical glue

Purdue University associate professor Julie Liu, at left, and doctoral student Sydney Hollingshead, prepare to test a new protein-based adhesive underwater. (Purdue University image/Erin Easterling)


Rossmann graphicNew mechanism to destroy viruses could lead to future therapies

Researchers at Purdue University have uncovered the way some antibodies neutralize infections caused by viruses.


Slider algaeTechnology could transform microalgae into bio-based chemicals to increase biofeedstock, reduce landfill waste

Gen3Bio Inc., a Purdue Foundry-affiliated company, is developing a unique process that could more effectively and affordably transform microalgae into bio-based chemicals to maximize the value of biofeedstock and reduce landfill waste.


Purdue researchers combining data and technology to make agriculture more sustainable

Due to the large usage of water in agriculture, many California communities no longer have running water, and collapsing aquifers have caused roads and buildings to sink several feet. Purdue University electrical and computer engineering professor David Ebert is using data collected from agricultural sites to respond to these problems.


Imaging recordingMRI device could bridge neuro-technologies for medical diagnostics, increase patient safety

A technology being developed at Purdue University could provide an affordable, smart, self-learning device that, when placed into existing MRI machines could allow medical professionals to monitor patients more effectively and safely, by performing concurrent medical imaging and recording for diagnostic purposes.


On Target compoundOn Target Laboratories’ cancer illuminating technology receives Special Protocol Assessment from FDA

On Target Laboratories LLC, a company developing a unique fluorescent imaging technology that could help surgeons identify and remove more cancerous tissue, has received Special Protocol Assessment approval from the Food and Drug Administration for its Phase 3 ovarian cancer intraoperative imaging clinical trial.


Research news archive

Purdue University, 610 Purdue Mall, West Lafayette, IN 47907, (765) 494-4600

© 2015-17 Purdue University | An equal access/equal opportunity university | Copyright Complaints | Maintained by Office of Strategic Communications

Trouble with this page? Disability-related accessibility issue? Please contact News Service at purduenews@purdue.edu.